RAF antisense oligonucleotide as a tumor radiosensitizer

Oncogene

Volumn 22, Issue 37 REV. ISS. 3, 2003, Pages 5876-5884

  Kasid, Usha ^a   Dritschilo, Anatoly ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antisense; Clinical relevance; In vivo potency; Liposomal oligonucleotide drug; Radiation response; Radioresistance; RAF 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; 2 MORPHOLINO 8 PHENYLCHROMONE; 7 HYDROXYSTAUROSPORINE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CETUXIMAB; CGP 69846A; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GEFITINIB; LIPOSOME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LM 609; OBLIMERSEN; RADIOSENSITIZING AGENT; RAF PROTEIN; SEMAXANIB;

ANTINEOPLASTIC ACTIVITY; CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; DRUG DISTRIBUTION; DRUG FORMULATION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE FUNCTION; GENE STRUCTURE; HUMAN; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; ANIMAL; NEOPLASM; RADIATION EXPOSURE;

OXY;

ANIMALS; HUMANS; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-RAF;

EID: 0141634058     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206700     Document Type: Review

References (142)

1. Agrawal S. (1996). Trends Biotechnol., 14, 376-387.
2. Agrawal S. (1999). Antisense Nucleic Acid Drug Dev., 9, 371-375.
3. Aplin AE, Howe A, Alahari SK and Juliano RL. (1998). Pharmacol. Rev., 50, 197-263.
4. App H, Hazan R, Zilberstein A, Ullrich A, Schlessinger J and Rapp U. (1991). Mol. Cell. Biol., 11, 913-919.
5. Awada A, Hendlisz A, Gil T, Bleiberg H, Bartholomeus S, De Valeriola D, Dewitte M, Coppieters S, Moeller J, De Becker D, Meert A and Piccart M. (2001). Proceedings of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications, Miami Beach, Abstract 569, p. 116.
6. Ballif BA and Blenis J. (2001). Cell Growth Differ., 12, 307-408.
7. Bar-Sagi D and Hall A. (2000). Cell, 103, 227-238.
8. Bertrand F, Philippe C, Antoine PJ, Baud L, Groyer A, Capeau J and Cherqui G. (1995). J. Biol. Chem., 270, 24435-24441.
9. Bianco C, Tortora G, Bianco R, Caputo R, Veneziani BM, Damiano V, Troiani T, Fontanini G, Raben D, Pepe S, Bianco AR and Ciardiello F. (2002). Clin. Cancer Res., 8, 3250-3258.
10. Broustas CG, Grammatikakis N, Eto M, Dent P, Brautigan DL and Kasid U. (2002). J. Biol. Chem., 277, 3053-3059.
11. Bruder JT, Heidecker G and Rapp UR. (1992). Genes Devel., 6, 545-556.
12. Canman CE, Gilmer TM, Coutts SB and Kastan MB. (1995). Genes Devel., 9, 600-611.
13. Carter S, Auer KL, Birrer M, Fisher PB, Schmidt-Ulrich R, Valerie K, Mikkelsen R and Dent P. (1998). Oncogene, 16, 2787-2796.
14. Chaudhary A, King WG, Mattaliano MD, Frost JA, Diaz B, Morrison DK, Cobb MH, Marshall MS and Brugge JS. (2000). Curr. Biol., 10, 551-554.
15. Chen J, Fujii K, Zhang L, Roberts T and Fu H. (2001). Proc. Natl. Acad. Sci. USA, 98, 7783-7788.
16. Chen Q, Lin TH, Der CJ and Juliano RL. (1996). J. Biochem. Chem., 271, 18122-18127.
17. Crooke ST. (1992). Annu. Rev. Pharmacol. Toxicol., 32, 329-376.
18. Cunningham CC, Holmlund JT, Schiller JH, Geary RS, Kwoh JT, Dorr A and Nemunaitis JA. (2000). Clin. Cancer Res., 6, 1626-1631.
19. Dai Y, Yu C, Singh V, Tang L, Wang Z, McInistry R, Dent P and Grant S. (2001). Cancer Res., 61, 5106-5115.
20. D'Angelo G, Lee H and Weiner RI. (1997). J. Cell. Biochem., 67, 353-366.
21. del Peso L, Gonzalez-Garcia M, Page C, Herrera R and Nunez G. (1997). Science, 278, 687-689.
22. Dent P, Reardon DB, Park JS, Bowers G, Logsdon C, Valerie K and Schmidt-Ullrich R. (1999). Mol. Biol. Cell., 10, 2493-2506.
23. Devary Y, Gottlieb RA, Smeal T and Karin M, (1992). Cell, 71, 1081-1091.
24. Dhillon AS and Kolch W. (2002). Arch. Biochem. Biophy., 404, 3-9.
25. Dhillon AS, Meikle S, Yazici Z, Eulitz M and Kolch W. (2002a). EMBO J., 21, 64-71.
26. Dhillon AS, Pollock C, Steen H, Shaw PE, Mischak H and Kolch W. (2002b). Mol. Cell. Biol., 22, 3237-3246.
27. Dritschilo A, Huang C, Strauss L, Fleming C, Rahman A, Rudin C, Collins B, Marshall J, Singh A, Zhang C, Kumar D, Gokhale P and Kasid U. (2002). Proc. Amer. Soc. Clin. Onc., 21, 28a, Abstract # 107.
28. Dumaz N, Light Y and Marais R. (2002). Mol. Cell. Biol., 22, 3717-3728.
29. Eliceiri BP and Cheresh DA. (1999). J. Clin. Invest., 103, 1227-1230.
30. Eliceiri BP, Klemke R, Strömblad S and Cheresh DA. (1998). J. Cell Biol., 140, 1255-1263.
31. Felding-Habermann B, Mueller BM, Romerdahl CA and Cheresh DA. (1992). J. Clin. Invest., 89, 2018-2022.
32. Finco TS and Baldwin Jr A. (1993). J. Biol. Chem., 268, 17676-17679.
33. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA and Cheresh DA. (1995). Science, 270, 1500-1502.
34. Frost JA, Swantek JL, Stippec S, Yin MJ, Gaynor R and Cobb MH. (2000). J. Biol. Chem., 275, 19693-19699.
35. Fuhrmann G, Leisser C, Rosenberger G, Grusch M, Huettenbrenner S, Halama T, Mosberger I, Sasgary S, Cerni C and Krupitza G. (2001). Oncogene, 20, 4542-4553.
36. Garcia-Chaumont Ch, Seksek O, Grzybowska J, Borowski E and Bolard J. (2000). Pharmacol. Ther., 87, 255-277.
37. Geng L, Donnelly E, McMahon G, Lin PC, Sierra-Rivera E, Oshinka H and Hallahan D. (2001). Cancer Res., 61, 2413-2419.
38. Gokhale PC, McRae D, Monia B, Bagg A, Rahman A, Dritschilo A and Kasid U. (1999). Antisense Nucleic Acid Drug Dev., 9, 191-201.
39. Gokhale PC, Soldatenkov V, Wang F-W, Rahman A, Dritschilo A and Kasid U. (1997). Gene Therapy, 4, 1289-1299.
40. Gokhale PC, Zhang C, Newsome JT, Pei J, Ahmad I, Rahman A, Dritschilo A and Kasid U. (2002). Clin. Cancer Res., 8, 3611-3621.
41. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW and Weichselbaum RR. (1999). Cancer Res., 59, 3374-3378.
42. Grana TM, Rusyn EV, Zhou H, Sartor CI and Cox AD. (2002). Cancer Res., 62, 4142-4150.
43. Grugel S, Finkenzeller G, Weindel K, Barleon B and Marmé D. (1995). J. Biol. Chem., 270, 25915-25919.
44. Gupta AK, Bakanauskas VJ, Cerniglia GJ, Cheng Y, Bernhard EJ, Muschel RJ and McKenna WG. (2001). Cancer Res., 61, 4278-4282.
45. Gupta AK, McKenna WG, Weber CN, Feldman MD, Goldsmith JD, Mick R, Machtay M, Rosenthal DI, Bakanauskas VJ, Cerniglia GJ, Bernhard EJ, Weber RS and Muschel RJ. (2002). Clin. Cancer Res., 8, 885-892.
46. Gutheil JC, Campbell TN, Pierce PR, Watkins JD, Huse WD, Bodkin DJ and Cheresh DA. (2000). Clin. Cancer Res., 6, 3056-3061.
47. Haimovitz-Friedman A, Balaban N, McLoughlin M, Ehleiter D, Michaeli J, Vlodavsky I and Fuks Z. (1994). Cancer Res., 54, 2591-2597.
48. Haimovitz-Friedman A, Vlodavsky I, Chaudhuri A, Witte L and Fuks Z. (1991). Cancer Res., 51, 2552-2558.
49. Hallahan DE, Virudachalam S, Sherman ML, Huberman E, Kufe DW and Weichselbaum RR. (1991). Cancer Res., 51, 4565-4569.
50. Henry SP, Giclas PC, Leeds J, Pangburn M, Auletta C, Levin AA and Kornbrust DJ. (1997). J. Pharm. Expt. Ther., 281, 810-816.
51. Holmlund J, Nemunaitis J, Schiller J, Dorr A and Kisner D. (1998). Proc. Am. Soc. Clin. Oncol., 17, 210a, Abstract 811.
52. Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R and Cheresh DA. (2002). Science, 296, 2404-2407.
53. Huang SM, Bock JM and Harari PM. (1999). Cancer Res., 59, 1935-1940.
54. Huser M, Luckett J, Chiloeches A, Mercer K, Iwobi M, Giblett S, Sun XM, Brown J, Marais R and Pritchard C. (2001). EMBO J., 20, 1940-1951.
55. Janosch P, Kieser A, Eulitz M, Lovric J, Sauer G, Reichert M, Gounari F, Buescher D, Baccarini M, Mischak H and Kolch W. (2000). FASEB J., 14, 2008-2021.
56. Kasid U, Olah Z, Anderson W and Dritschilo A. (1991). Intl. Congress Rad. Res., I, 242, Abstract P16-03.
57. Kasid U, Pfeifer A, Brennan T, Beckett M, Weichselbaum RR, Dritschilo A and Mark GE. (1989). Science, 243, 1354-1356.
58. Kasid U, Pfeifer A, Weichselbaum RR, Dritschilo A and Mark GE. (1987). Science, 237, 1039-1041.
59. Kasid U and Suy S. (1998). Apoptosis Genes. Wilson J, Booth C, Potten CS (eds). Kluwer Academic Publishers: Norwell, MA, pp. 85-118.
60. Kasid U, Suy S, Dent P, Ray S, Whiteside TLW and Sturgill T. (1996). Nature, 382, 813-816.
61. Kerkhoff E and Rapp UR. (1998). Oncogene, 17, 1457-1462.
62. Kharbanda S, Saleem A, Shafman T, Emoto Y, Weichselbaum R and Kufe D. (1994). Proc. Natl. Acad. Sci. USA, 91, 5416-5420.
63. Khatib A-M, Fallavollita L, Wancewicz EV, Monia BP and Brodt P. (2002). Cancer Res., 62, 5393-5398.
64. Khodarev NN, Park JO, Yu J, Gupta N, Nodzenski E, Roizman B and Weichselbaum RR. (2001). Proc. Natl. Acad. Sci. USA, 98, 12665-12670.
65. King WG, Mattaliano MD, Chan TO, Tsichlis PN and Brugge JS. (1997). Mol. Cell. Biol., 17, 4406-4418.
66. Kolch W. (2000). Biochem. J., 351, 289-305.
67. Kolch W, Heidecker G, Lloyd P and Rapp UR. (1991). Nature, 349, 426-428.
68. Koller E, Gaarde WA and Monia BP. (2000). Science, 21, 142-148.
69. Kozin SV, Boucher Y, Hicklin DJ, Bohlen P, Jain RK and Suit HD. (2001). Cancer Res., 61, 39-44.
70. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA, Twito DI, Morton RF, Veeder MH, Witzig TE, Cha S and Vidyarthi SC. (1991). N. Engl. J. Med., 324, 709-715.
71. Kyriakis JM, App H, Zhang X-F, Banerjee P, Brautigan D, Rapp U and Avruch J. (1992). Nature, 358, 417-421.
72. Lammering G, Valerie K, Lin P-S, Mikkelsen RB, Contessa JN, Feden JP, Farnsworth J, Dent P and Schmidt-Ullrich RK. (2001). Clin. Cancer Res., 7, 682-690.
73. Lau QC, Brusselbach S and Muller R. (1998). Oncogene, 16, 1899-1902.
74. Leonetti C, Biroccio A, Benassi B, Stringaro A, Stoppacciaro A, Semple SC and Zupi G. (2001). Cancer Gene Ther., 8, 459-468.
75. Lizcano JM, Morrice N and Cohen P. (2000). Biochem. J., 349, 547-557.
76. Marshall CJ. (1996). Nature, 383, 127-128.
77. Meighan-Mantha RL, Riegel AT, Suy S, Harris V, Wang F-H, Lozano C, Whiteside TL and Kasid U. (1999). Mol. Cell. Biochem., 199, 209-215.
78. Mikula M, Schreiber M, Husak Z, Kucerova L, Rüth J, Wieser R, Zatloukal K, Beug H, Wagner EF and Baccarini M. (2001). EMBO J., 20, 1952-1962.
79. Milas L, Mason K, Hunter N, Peterson S, Yamakawa M, Ang K, Mendelsohn J and Fan Z. (2000). Clin. Cancer Res., 6, 701-708.
80. Moelling K, Heimann B, Beimling P, Rapp UR and Sander T. (1984). Nature, 312, 558-561.
81. Monia BP, Holmlund J and Dorr AF. (2000). Cancer Invest., 18, 635-650.
82. Monia BP, Johnston JF, Geiger T, Muller M and Fabbro D. (1996). Nature Med., 2, 668-675.
83. Monteith DK, Geary RS, Leeds JM, Johnston J, Monia BP and Levin AA. (1998). Toxicol. Sci., 46, 365-375.
84. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM and Mutch DG. (1999). N. Engl. J. Med., 340, 1137-1143.
85. Morrison DK, Kaplan DR, Rapp U and Roberts TM. (1988). Proc. Natl. Acad. Sci. USA, 85, 8855-8859.
86. Nemunaitis J, Holmlund JT, Kraynak M, Richards D, Bruce J, Ognoskie N, Kwoh TJ, Geary R, Dorr A, Von Hoff D and Eckhardt SG. (1999). J. Clin. Oncol., 17, 3586-3595.
87. O'Dwyer PJ, Stevenson JP, Gallagher M, Cassella A, Vasilevskaya I, Monia BP, Holmlund J, Dorr AF and Yao K-S. (1999). Clin. Cancer Res., 5, 3977-3982.
88. Pagnan G, Stuart DD, Pastorino F, Raffaghello L, Montaldo PG, Allen TM, Calabretta B and Ponzoni M. (2000). J. Natl. Cancer Inst., 92, 253-261.
89. Pandey SK, Theberge JF, Bernier M and Srivastava AK. (1999). Biochemistry, 38, 14667-14675.
90. Patel S, Wang F-W, Whiteside TL and Kasid U. (1997). Mol. Med., 3, 647-685.
91. Peters SJ, Withers HR, Thames HD and Fletcher GH. (1982). Int. J. Radiat. Oncol. Biol. Phys., 8, 101-108.
92. Pfeifer A, Mark G, Leung S, Dougherty M, Spillare E and Kasid U. (1998). Biochem. Biophys. Res. Comm., 252, 481-486.
93. Pirollo KF, Garner R, Yuan S-Y, Li L, Blattner WA and Chang EH. (1989). Int. J. Radiat. Oncol., 55, 783-796.
94. Pirollo KF, Hao Z, Rait A, Ho CW and Chang EH. (1997). Biochem. Biophys. Res. Commun., 230, 196-201.
95. Podar K, Tai Y, Davies FE, Lentzsch S, Sattler M, Hideshima T, Lin BK, Gupta D, Shima Y, Chauhan D, Mitsiades C, Raje N, Richardson P and Anderson KC. (2001). Blood, 98, 428-435.
96. Poggi MM, Coleman N and Mitchell JB. (2001). Carr. Probl. Cancer, 25, 329-412.
97. Rasouli-Nia A, Liu D, Perdue S and Britten RA. (1998). Clin. Cancer Res., 4, 1111-1116.
98. Reardon DB, Contessa JN, Mikkelsen RB, Valerie K, Amir C, Dent P and Schmidt-Ullrich RK. (1999). Oncogene, 18, 4756-4766.
99. Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M and McCormick F. (2000). Cell, 103, 321-330.
100. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD and Glass DJ. (1999). Science, 286, 1738-1741.
101. Rosenzweig KE, Youmell MB, Palayoor ST and Price BD. (1997). Clin. Cancer Res., 3, 1149-1156.
102. Rudin C, Bertucci D, Strauss L, Fleming C, Kindler H, Fleming G, Zhang C, Kumar D, Gokhale P, Kasid U and Ratain M. (2002). Proc. Am. Soc. Clin. Onc., 21, 9b, Abstract # 1845.
103. Rudin CM, Holmlund J, Fleming GF, Mani S, Stadler WM, Schumm P, Monia BP, Johnston JF, Geary R, Yu RZ, Kwoh TJ, Dorr FA and Ratain MJ. (2001a). Clin. Cancer Res., 7, 1214-1220.
104. Rudin C, Otterson GA, George CM et al. (2001b). Proc. Am. Soc. Clin. Oncol., 20, 322a, Abstract 1283.
105. Salomoni P, Wasik MA, Riedel RF, Reiss K, Choi JK, Skorski T and Calabretta B. (1998). J. Exp. Med., 187, 1995-2007.
106. Schlaepfer DD, Jones KC and Hunter T. (1998). Mol. Cell. Biol., 18, 2571-2585.
107. Schulze A, Lehmann K, Jefferies HBJ, McMahon M and Downward J. (2001). Genes Devel., 15, 981-994.
108. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tecle H, Barrett SD, Bridges A, Przybranowski S, Leopold WR and Saltiel Ar. (1999). Nat. Med., 5, 810-816.
109. Shengfeng Li and Sedivy JM. (1993). Proc. Natl. Acad. Sci. USA, 90, 9247-9251.
110. Shu X, Wu W, Mosteller RD and Broek D. (2002). Mol. Cell. Biol., 22, 7758-7768.
111. Skorski T, Nieborowska-Skorska M, Szczylik C, Kanakaraj P, Perrotti D, Zon G, Gewirtz A, Perussia B and Calabretta B. (1995). Cancer Res., 55, 2275-2278.
112. Soldatenkov VA, Dritschilo A, Wang F-W, Olah Z, Anderson WB and Kasid U. (1997). Cancer J. Sci. Am., 3, 13-20.
113. Stein CA. (2001). J. Clin. Invest., 108, 641-644.
114. Stevenson JP, Yao KS, Gallagher M, Friedland D, Mitchell EP, Cassella A, Monia B, Kwah TJ, Yu R, Holmlund J, Dorr A and O'Dwyer PJ. (1999). J. Clin. Oncol., 17, 2227-2236.
115. Strumberg D, Schuehly U, Moeller JG et al. (2001). Proc. Am. Soc. Clin. Oncol., 20, 83a, Abstract 330.
116. Sun H, King AJ, Diaz HB and Marshall MS. (2000). Curr. Biol., 10, 281-284.
117. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X and Wu H. (1999). Proc. Natl. Acad. Sci. USA, 96, 6199-6204.
118. Suy S, Anderson WB, Dent P and Kasid U. (1997). Oncogene, 14, 53-61.
119. Takahashi T, Ueno H and Shibuya M. (1999). Oncogene, 18, 2221-2230.
120. Tari AM, Stephens C, Rosenblum M and Lopez-Berestein G. (1998). J. Liposome Res., 8, 251-264.
121. Tenzer A, Zingg D, Rocha S, Hemmings B, Fabbro D, Glanzmann C, Schubiger PA, Bodis S and Pruschy M. (2001). Cancer Res., 61, 8203-8210.
122. Tortora G and Ciardiello F. (2002). Ann. NY Acad. Sci., 968, 139-147.
123. Troppmair J, Cleveland JL, Askew DS and Rapp UR. (1992). Curr. Top. Microbiol. Immunol., 182, 453-460.
124. Turner B, Rapp U, App H, Greene M, Dobashi K and Reed J. (1991). Proc. Natl. Acad. Sci. USA, 88, 1227-1231.
125. Veikkola T, Karkkainen, Claesson-Welsh L and Alitalo K. (2000). Cancer Res., 60, 203-212.
126. Virdee K, Parone PA and Tolkovsky AM. (2000). Curr. Biol., 10, 1151-1154.
127. von Gise A, Lorenz P, Wellbrock C, Hemmings B, Berberich-Siebelt F, Rapp UR and Troppmair J. (2001). Mol. Cell. Biol., 21, 2324-2336.
128. Wang HG, Rapp UR and Reed JC. (1996). Cell, 87, 629-638.
129. Wang S, Ghosh RN and Chellaeppan SP. (1998). Mol. Cell. Biol., 18, 7487-7498.
130. Ward Y, Wang W, Woodhouse E, Linnoila I, Liotta L and Kelly K. (2001). Mol. Cell. Biol., 21, 5958-5969.
131. Waters JS, Webb A, Cunningham D, Clarke PA, Raynaud F, di Stefano F and Cotter FE. (2000). J. Clin. Oncol., 18, 1812-1823.
132. Weichselbaum RR, Beckett MA, Schwartz JL and Dritschilo A. (1988). Int. J. Radiat. Oncol. Biol. Phys., 15, 575-579.
133. Weichselbaum RR, Hallahan DE, Sukhatme V, Dritschilo A, Sherman ML and Kufe DW. (1991). J. Natl. Cancer Inst., 83, 480-484.
134. Weissinger EM, Eissner G, Grammar C, Fackler S, Haefner B, Yoon LS, Lu KS, Bazarov A, Sedivy JM, Mischak H and Kolch W. (1997). Mol. Cell. Biol., 17, 3229-3241.
135. Wennstrom S and Downward J. (1999). Mol. Cell. Biol., 19, 4279-4288.
136. Wick W, Furnari FB, Naumann U, Cavenee WK and Weller M. (1999). Oncogene, 18, 3936-3943.
137. Wu X, Senechal K, Neshat MS, Whang YE and Sawyers CL. (1998). Proc. Natl. Acad. Sci. USA, 95, 15587-15591.
138. Xu XS, Vanderziel C, Bennett CF and Monia BP. (1998). J. Biol. Chem., 273, 33230-33238.
139. Yeung K, Janosch B, McFerran B, Rose DW, Mischak H, Sedivy JM and Kolch W. (2000). Mol. Cell. Biol., 20, 3079-3085.
140. Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W and Sedivy JM. (2001). Mol. Cell. Biol., 21, 7207-7217.
141. Zhong J, Troppmair J and Rapp UR. (2001). Oncogene, 20, 4807-4816.
142. Zimmermann S and Moelling K. (1999). Science, 286, 1741-1744.